Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-21-031349

Options or other derivatives

  • Chief Financial Officer acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Garcia-Parada Carlos · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-09-13 Grant or award : show line 1 in the form Stock Option (Right to Buy) +40,000 $35.60 2031-09-13 40,000 40,000 D
Loading xslF345X03/form4.xml…